Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for ROPIVACAINE HYDROCHLORIDE

Ingredient

ROPIVACAINE HYDROCHLORIDE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
NAROPIN	10MG	SOLUTION	Resolved	2021-01-04	2021-09-03	130813
NAROPIN	10MG	SOLUTION	Resolved	2018-02-26	2019-01-12	40951
NAROPIN	10MG	SOLUTION	Resolved	2018-01-02	2019-04-04	34491
NAROPIN	10MG	SOLUTION	Resolved	2017-09-18	2017-10-13	22243
NAROPIN	5MG	SOLUTION	Actual shortage	2025-12-17	2026-01-15	274532
NAROPIN	5MG	SOLUTION	Resolved	2023-11-06	2024-02-13	209405
ROPIVACAINE HYDROCHLORIDE INJECTION USP	10MG	SOLUTION	Resolved	2017-04-28	2018-10-02	8417
ROPIVACAINE HYDROCHLORIDE INJECTION USP	5MG	SOLUTION	Resolved	2022-01-27	2022-02-10	153749
ROPIVACAINE HYDROCHLORIDE INJECTION USP	5MG	SOLUTION	Resolved	2019-02-21	2019-09-12	76554
ROPIVACAINE HYDROCHLORIDE INJECTION USP	5MG	SOLUTION	Resolved	2018-05-10	2018-08-30	49024

Previous
1
2
3
4
5
…
7
Next

Showing 21 to 30 of 62

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
NAROPIN	2MG	SOLUTION	Reversed	2025-06-09	2025-06-09	260037
NAROPIN	2MG	SOLUTION	Discontinued	2025-06-23	2025-06-23	260981
NAROPIN	2MG	SOLUTION	Discontinued	2025-07-22	2025-07-22	263320
ROPIVACAINE HYDROCHLORIDE INJECTION USP	5MG	SOLUTION	Discontinued	2022-09-30	2022-10-02	170502
ROPIVACAINE HYDROCHLORIDE INJECTION USP	10MG	SOLUTION	Discontinued	2022-09-30	2022-10-02	170496
ROPIVACAINE HYDROCHLORIDE INJECTION USP	10MG	SOLUTION	Discontinued	2022-09-30	2022-10-02	170499

1

Showing 1 to 6 of 6